| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 01/03/1997 | CA2224976A1 New family of linear antimicrobial peptides from hagfish intestine |
| 01/03/1997 | CA2224697A1 Rotavirus enterotoxin nsp4 and methods of using same |
| 01/03/1997 | CA2224646A1 Chimeric leptin fused to immunoglobulin domain and use |
| 01/03/1997 | CA2224625A1 P-selectin ligands and related molecules and methods |
| 01/03/1997 | CA2224560A1 Anti-metastatic and anti-angiogenic pharmaceutical compositions |
| 01/03/1997 | CA2223792A1 Urocortin peptides |
| 01/03/1997 | CA2221981A1 Novel peptides for use in treatment of t-cell mediated cartilage destruction in autoimmune diseases |
| 01/02/1997 | EP0751221A1 Recombinant mistletoe lectin (rML) |
| 01/02/1997 | EP0751220A1 Highly purified protein, production and use thereof |
| 01/02/1997 | EP0751219A1 Platelet aggregation inhibitors |
| 01/02/1997 | EP0751217A2 Enhancing keratinocyte migration with clostridiopeptidase-A-collagenase |
| 01/02/1997 | EP0751149A2 Phenylalanine substitution analogues of magainin peptides |
| 01/02/1997 | EP0751148A2 D-amino acid substitution analogues of Magainin peptides |
| 01/02/1997 | EP0751147A1 Toxoplasma gondii antigen, its production and use |
| 01/02/1997 | EP0750912A2 Batroxobin containing medicaments for the treatment or prophylaxis of ischemia-reperfusion injury |
| 01/02/1997 | EP0750846A1 Balhimycine products and use for increasing animal performance |
| 01/02/1997 | EP0750743A1 Methods and devices for automatic assessment of corn |
| 01/02/1997 | EP0750679A1 Isolated, tyrosinase derived peptides and uses thereof |
| 01/02/1997 | EP0750676A1 Recombinant adenoviruses coding for brain-derived neurotrophic factor (bdnf) |
| 01/02/1997 | EP0750675A1 RECOMBINANT ADENOVIRUSES CODING FOR ACIDIC FIBROBLAST GROWTH FACTOR (aFGF) |
| 01/02/1997 | EP0750674A1 RECOMBINANT ADENOVIRUSES FOR GLIAL MATURATION FACTOR BETA (GMF-$g(b)) |
| 01/02/1997 | EP0750673A1 Transgenic production of oligosaccharides and glycoconjugates |
| 01/02/1997 | EP0750672A1 Dna sequences for matrix metalloproteases, their production and use |
| 01/02/1997 | EP0750669A1 MODIFIED PAPILLOMA VIRUS L2 PROTEIN AND VLPs FORMED THEREFROM |
| 01/02/1997 | EP0750668A1 NOVEL MUTEINS OF IFN-$g(b) |
| 01/02/1997 | EP0750666A1 HUMAN trk RECEPTORS AND NEUROTROPHIC FACTOR INHIBITORS |
| 01/02/1997 | EP0750664A1 Reproduction and utilization of functional human tissue |
| 01/02/1997 | EP0750637A1 Dna encoding cai resistance proteins and uses thereof |
| 01/02/1997 | EP0750636A1 Methods to diagnose and treat hiv-1 infection |
| 01/02/1997 | EP0750635A1 Peptides inhibiting the release of pepsine |
| 01/02/1997 | EP0750633A1 Enhancement of antitumor therapy with hemoglobin-based conjugates |
| 01/02/1997 | EP0750632A1 Ion-channel forming amphiphilic peptides having n-terminal modifications |
| 01/02/1997 | EP0750631A1 Novel mercaptoacetylamido 1,3,4,5-tetrahydro-benzo(c)azepin-3-one disulfide derivatives useful as inhibitors of enkephalinase and ace |
| 01/02/1997 | EP0750628A1 Fibroblast growth factor-10 |
| 01/02/1997 | EP0750626A1 Corpuscles of stannius protein, stanniocalcin |
| 01/02/1997 | EP0750609A1 Isoprenyl transferase inhibitors |
| 01/02/1997 | EP0750515A1 Low molecular weight hyaluronic acid with peptide or protein |
| 01/02/1997 | EP0750514A1 Immunotherapeutic method of treating cancerous diseases by administration of gamma globulins |
| 01/02/1997 | EP0750512A1 A medical use of matrix metalloproteinase inhibitors for inhibiting tissue contraction |
| 01/02/1997 | EP0750511A1 Treating inflammation via the administration of specific sulfatase enzymes and/or sulfation inhibitor |
| 01/02/1997 | EP0750510A1 Skin treatment composition |
| 01/02/1997 | EP0750509A1 Use of il-12 and il-12 antagonists in the treatment of autoimmune diseases |
| 01/02/1997 | EP0750508A1 RETROPEPTIDES, ANTIBODIES THERETO, AND USES THEREOF FOR VACCINATION AND $i(IN VITRO) DIAGNOSIS |
| 01/02/1997 | EP0750507A1 PROTEASOME REGULATION OF NF-$g(k)B ACTIVITY |
| 01/02/1997 | EP0750506A1 Broad spectrum antimicrobial compounds and methods of use |
| 01/02/1997 | EP0750505A1 Immunotherapy of cancer with allogeneic lymphocytes |
| 01/02/1997 | EP0750504A1 Use of complex carbohydrate to diminish hypoglycemia in patients with diabetes mellitus |
| 01/02/1997 | EP0750503A1 Ribozyme therapy for restenosis |
| 01/02/1997 | EP0750494A1 Hydrophobic drug delivery systems |
| 01/02/1997 | EP0750493A1 Method for making chewable tablets based on troxerutine, calcium carbonate, calcium phosphate, arginine aspartate, arginine glutamate, amoxicillin, a combination of calcium carbonate and magnesium carbonate, and a combination of aluminium hydroxide and magnesium hydroxide |
| 01/02/1997 | EP0750458A1 Terminal complement inhibitor fusion genes and proteins |
| 01/02/1997 | EP0750457A1 Targeted cytolysis of hiv-infected cells by chimeric cd4 receptor-bearing cells |
| 01/02/1997 | EP0607258B1 Use of ifn-gamma for the treatment of infections in transplant recipients |
| 01/02/1997 | EP0556345B1 Retroviral vectors useful for gene therapy |
| 01/02/1997 | EP0552178B1 Modified ribozymes |
| 01/02/1997 | EP0512090B1 Treatment of inflammation |
| 01/02/1997 | EP0477295B1 Platelet aggregation inhibitors |
| 01/02/1997 | DE19526386C1 Papillomviren, Mittel zu deren Nachweis sowie zur Therapie von durch sie verursachten Erkrankungen Papillomaviruses means for their detection as well as for the treatment of diseases caused by them |
| 01/02/1997 | DE19523935A1 Pumpvorrichtung Pumping device |
| 01/02/1997 | DE19523660A1 Antigens with characteristics of retro-virus |
| 01/01/1997 | CN1139455A Thrombin mutants |
| 01/01/1997 | CN1139427A Malarial aspartic protease inhibitors |
| 01/01/1997 | CN1139386A Microcapsules, method of making and their use |
| 01/01/1997 | CN1139385A Aqueous prolonged release formulation |
| 01/01/1997 | CN1139115A Anti-aV-integrin monoclonal antibody |
| 01/01/1997 | CN1138983A Preparation of drug composition |
| 12/31/1996 | US5589624 Antifungal polypeptide and process for its production |
| 12/31/1996 | US5589582 Polynucleotides en coding porcine cytokines |
| 12/31/1996 | US5589580 Endoribonuclease active compounds with hybrid regions from hybrids for target dna or rna |
| 12/31/1996 | US5589579 Gene sequence and probe for a marker of non-small cell lung carinoma |
| 12/31/1996 | US5589572 Process for production of inhibited forms of activated blood factors |
| 12/31/1996 | US5589571 Process for production of inhibited forms of activated blood factors |
| 12/31/1996 | US5589568 Methods and compositions for modulating G protein action |
| 12/31/1996 | US5589516 Liquid preparation of antithrombin-III and stabilizing method therefor |
| 12/31/1996 | US5589508 Use of an emulsion to prepare an intravensously administered medicament for treating skin diseases |
| 12/31/1996 | US5589503 Endoparasiticidal compositions |
| 12/31/1996 | US5589468 Method for providing nutrition to elderly patients |
| 12/31/1996 | US5589463 Oral delivery of biologically active substances bound to vitamin B12 |
| 12/31/1996 | US5589462 Freezing a platelet factor enriched biological adhesive, isolation a cryoprecipitate from plasma |
| 12/31/1996 | US5589461 Active substance for inhibiting the proliferation rate of hepatocytes |
| 12/31/1996 | US5589460 Modification of melanotrophic release inhibiting factor |
| 12/31/1996 | US5589459 Synthetic peptides for detoxification of bacterial endotoxins and for the prevention and treatment of septic shock |
| 12/31/1996 | US5589458 Compounds that inhibit T cell proliferation and methods for using the same |
| 12/31/1996 | US5589457 Process for the synchronization of ovulation |
| 12/31/1996 | US5589455 Cyclosporin-containing soft capsule compositions |
| 12/31/1996 | US5589453 Viricides |
| 12/31/1996 | US5589452 Analogs of parathyroid hormone and parathyroid hormone related peptide: synthesis and use for the treatment of osteoporosis |
| 12/31/1996 | US5589451 Methods and treaments for corneal healing with hepatocyte and keratinocyte growth factors |
| 12/31/1996 | US5589380 Isolated DNA molecule encoding SHET1 of Shigella flexneri 2a and mutant Shigella flexneri 2a |
| 12/31/1996 | US5589375 Dephosphorylation |
| 12/31/1996 | US5589374 Diabetogene rad: a type II diabetes specific gene |
| 12/31/1996 | US5589371 Polypeptides and yeast expression vectors for culture |
| 12/31/1996 | US5589363 DNA encoding tissue factor mutants useful for the treatment of myocardial infarction and coagulopathic disorders |
| 12/31/1996 | US5589361 Human tissue-type plasminogen activator variant |
| 12/31/1996 | US5589360 Polypeptide, DNA fragment encoding the same, drug composition containing the same and process for producing the same |
| 12/31/1996 | US5589359 Chimeric proteins |
| 12/31/1996 | US5589358 Ileal bile acid transporter compositions and methods |
| 12/31/1996 | US5589356 Cyclization |
| 12/31/1996 | US5589341 Origin of replication complex genes and methods of using the same |
| 12/31/1996 | US5589340 Process and primers for identifying nucleic acids encoding A-lineage conotoxin peptides |